KSHV 2.0: A Comprehensive Annotation of the Kaposi's Sarcoma-Associated Herpesvirus Genome Using NextGeneration Sequencing Reveals Novel Genomic and Functional Features

被引:224
|
作者
Arias, Carolina [1 ]
Weisburd, Ben [2 ]
Stern-Ginossar, Noam [3 ]
Mercier, Alexandre [1 ]
Madrid, Alexis S. [1 ]
Bellare, Priya [1 ]
Holdorf, Meghan [1 ]
Weissman, Jonathan S. [3 ]
Ganem, Don [1 ]
机构
[1] Novartis Inst Biomed Res, Dept Infect Dis, Emeryville, CA 94608 USA
[2] Novartis Vaccines & Diagnost, Bioinformat, Emeryville, CA USA
[3] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA USA
关键词
OPEN READING FRAMES; MURINE GAMMAHERPESVIRUS 68; PRIMARY EFFUSION LYMPHOMA; LATE GENE-EXPRESSION; RIBOSOMAL S6 KINASE; MESSENGER-RNA; IN-VIVO; TRANSCRIPTIONAL REGULATION; HUMAN-HERPESVIRUS-8; ENCODES; MODULATES AUTOREGULATION;
D O I
10.1371/journal.ppat.1003847
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Productive herpesvirus infection requires a profound, time-controlled remodeling of the viral transcriptome and proteome. To gain insights into the genomic architecture and gene expression control in Kaposi's sarcoma-associated herpesvirus (KSHV), we performed a systematic genome-wide survey of viral transcriptional and translational activity throughout the lytic cycle. Using mRNA-sequencing and ribosome profiling, we found that transcripts encoding lytic genes are promptly bound by ribosomes upon lytic reactivation, suggesting their regulation is mainly transcriptional. Our approach also uncovered new genomic features such as ribosome occupancy of viral non-coding RNAs, numerous upstream and small open reading frames (ORFs), and unusual strategies to expand the virus coding repertoire that include alternative splicing, dynamic viral mRNA editing, and the use of alternative translation initiation codons. Furthermore, we provide a refined and expanded annotation of transcription start sites, polyadenylation sites, splice junctions, and initiation/termination codons of known and new viral features in the KSHV genomic space which we have termed KSHV 2.0. Our results represent a comprehensive genome-scale image of gene regulation during lytic KSHV infection that substantially expands our understanding of the genomic architecture and coding capacity of the virus. Author Summary Kaposi's sarcoma-associated herpesvirus (KSHV) is a cancer-causing agent in immunocompromised patients that establishes long-lasting infections in its hosts. Initially described in 1994 and extensively studied ever since, KSHV molecular biology is understood in broad outline, but many detailed questions are still to be resolved. After almost two decades, specific aspects pertaining to the organization of the KSHV genome as well as the fate of the viral transcripts during the productive stages of infection remain unexplored. Here we use a systematic genome-wide approach to investigate changes in gene and protein expression during the productive stage of infection known as the lytic cycle. We found that the viral genome has a large coding capacity, capable of generating at least 45% more products than initially anticipated by bioinformatic analyses alone, and that it uses multiple strategies to expand its coding capacity well beyond what is determined solely by the DNA sequence of its genome. We also provide an expanded and highly detailed annotation of known and new genomic features in KSHV. We have termed this new architectural and functional annotation KSHV 2.0. Our results indicate that viral genomes are more complex than anticipated, and that they are subject to tight mechanisms of regulation to ensure correct gene expression.
引用
收藏
页数:23
相关论文
共 50 条
  • [41] Modulation of cell signaling pathways by kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)
    Blossom Damania
    Cell Biochemistry and Biophysics, 2004, 40 : 305 - 322
  • [42] Post-translational modifications of Kaposi's sarcoma-associated herpesvirus regulatory proteins - SUMO and KSHV
    Campbell, Mel
    Izumiya, Yoshihiro
    FRONTIERS IN MICROBIOLOGY, 2012, 3
  • [43] Repression of cancer-immunity regulator STING by Kaposi's Sarcoma-Associated Herpesvirus (KSHV) microRNA
    Paulsen, Kimberly
    Chan, Rosenna
    Gay, Lauren
    Renne, Rolf
    Ma, Zhe
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (03) : S41 - S41
  • [44] Kaposi's sarcoma-associated herpesvirus (KSHV) induces the expression of cytokines and growth factors that are required for survival of KSHV-associated malignancies
    Damania, Blossom
    Wang, Ling
    Dittmer, Dirk P.
    Tomlinson, Christine C.
    Sin, Sang-Hoon
    Debasmita, Roy
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2007, 27 (08): : 724 - 724
  • [45] Integrative systems control approach for reactivating Kaposi's sarcoma-associated herpesvirus (KSHV) with combinatory drugs
    Sun, Chien-Pin
    Usui, Takane
    Yu, Fuqu
    Al-Shyoukh, Ibrahim
    Shamma, Jeff
    Ren Sun
    Ho, Chih-Ming
    INTEGRATIVE BIOLOGY, 2009, 1 (01) : 123 - 130
  • [46] Functional activity of the complement regulator encoded by Kaposi's sarcoma-associated herpesvirus
    Spiller, OB
    Blackbourn, DJ
    Mark, L
    Proctor, DG
    Blom, AM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (11) : 9283 - 9289
  • [47] Genetics and functions of Kaposi's sarcoma-associated herpesvirus (KSHV) glycoproteins in virion egress, infectivity and tumorigenesis
    D'Auvergne, Oswald
    Subramanian, Ramesh
    CANCER RESEARCH, 2012, 72
  • [48] Characterization of Kaposi's sarcoma-associated herpesvirus (KSHV) K1 promoter activation by Rta
    Bowser, Brian S.
    Morris, Stephanie
    Song, Moon Jung
    Sun, Ren
    Damania, Blossom
    VIROLOGY, 2006, 348 (02) : 309 - 327
  • [49] The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8)
    Lagunoff, M
    Ganem, D
    VIROLOGY, 1997, 236 (01) : 147 - 154
  • [50] Distinct distribution of rare US genotypes of Kaposi's sarcoma-associated herpesvirus (KSHV) in South Texas: Implications for KSHV epidemiology
    Zhang, YJ
    Davis, TL
    Wang, XP
    Deng, JH
    Baillargeon, J
    Yeh, IT
    Jenson, HB
    Gao, SJ
    JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (01): : 125 - 129